The DOI matches its Crossref record; 101 of the 108 references it cites were found in a registry or an index, and 7 are not checked yet; 4 of the 101 sources its claims cite were checked for support.
Aging of hematopoietic stem cells
Open accessAbstract
Hematopoietic stem cells (HSCs) ensure a balanced production of all blood cells throughout life. As they age, HSCs gradually lose their self-renewal and regenerative potential, whereas the occurrence of cellular derailment strongly increases. Here we review our current understanding of the molecular mechanisms that contribute to HSC aging. We argue that most of the causes that underlie HSC aging result from cell-intrinsic pathways, and reflect on which aspects of the aging process may be reversible. Because many hematological pathologies are strongly age-associated, strategies to intervene in aspects of the stem cell aging process may have significant clinical relevance.
Verified 2026-10-06 · 7 references not checked yet
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
50 Not checked yet · 23 Own interpretation · 2 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Epigenetic genes that are relatively frequently affected in these conditions include DNMT3A, EZH2, TET2, and SETDB1.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Epigenetic reprogramming
What the sources say
- Partly supportedcites [74] Zink, 2017, Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly, Blood sourceExperimental — accuracy not yet measured
The ‘Association of driver mutations with clonal hematopoiesis’ section reports frequent mutations in DNMT3A and TET2 (93 and 76 individuals, respectively). Figure 2 includes SETDB1 among genes with detected mutations, but does not establish that it was relatively frequent; the passages do not report EZH2 as a frequently affected gene. Thus the paper supports only part of the four-gene list. (LLM, conf=0.88)
- Partly supportedcites [75] Xie, 2014, Age-related mutations associated with clonal hematopoietic expansion and malignancies, Nat Med sourceExperimental — accuracy not yet measured
The Results section on mutation frequencies reports that DNMT3A and TET2 were consistently mutated across the studied cohorts. It does not identify EZH2 or SETDB1 as relatively frequently affected; searches for both names found no supporting passage in our copy. Page numbers were not provided. (LLM, conf=0.88)
- Partly supportedcites [76] Jaiswal, 2014, Age-related clonal hematopoiesis associated with adverse outcomes, N Engl J Med sourceExperimental — accuracy not yet measured
The Results section (page unavailable) identifies DNMT3A and TET2 among the most commonly mutated genes, supporting those two examples. It names ASXL1 next, not EZH2 or SETDB1; searches for EZH2 and SETDB1 found no passage establishing either as relatively frequently affected. (LLM, conf=0.88)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
None of the sources cited for this claim have been checked yet.
In the paper
“young bone marrow cells, when transplanted into aged recipients, engraft worse than when transplanted into young recipients.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Cell-intrinsic vs cell-extrinsic mechanisms
What the sources say
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“the functional heterogeneity of the HSC population increases with age.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Heterogeneity of HSC aging
What the sources say
- Not checked yetcites [10] Dykstra, 2011, Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells, J Exp Med source
- Not checked yetcites [13] Sudo, 2000, Age-associated characteristics of murine hematopoietic stem cells, J Exp Med source
- Not checked yetcites [17] Beerman, 2010, Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion, Proc Natl Acad Sci USA source
- Not checked yetcites [32] Cho, 2008, A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells, Blood source
- Not checked yetcites [33] Ho, 2017, Autophagy maintains the metabolism and function of young and old stem cells, Nature source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“aging (also of the hematopoietic system) is at least qualitatively different in distinct strains of mice.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > HSC self-renewal and aging
What the sources say
- Not checked yetcites [30] De Haan, 1999, Genetic analysis of hemopoietic cell cycling in mice suggests its involvement in organismal life span, FASEB J source
- Not checked yetcites [31] de Haan, 1997, Intrinsic and extrinsic control of hemopoietic stem cell numbers: mapping of a stem cell gene, J Exp Med source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“hematological malignancies can result from a defective bone marrow environment.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Cell-intrinsic vs cell-extrinsic mechanisms
What the sources say
- Not checked yetcites [44] Zambetti, 2016, Mesenchymal inflammation drives genotoxic stress in hematopoietic stem cells and predicts disease evolution in human pre-leukemia, Cell Stem Cell source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“most of the proliferative burden resides with committed progenitors”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > HSC self-renewal and aging
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“transplanting aged HSCs in a young environment apparently cannot reverse these changes.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Cell-intrinsic vs cell-extrinsic mechanisms
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“in aged mice that display an overall increase in HSC pool size”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Heterogeneity of HSC aging
What the sources say
- Not checked yetcites [10] Dykstra, 2011, Clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells, J Exp Med source
- Not checked yetcites [13] Sudo, 2000, Age-associated characteristics of murine hematopoietic stem cells, J Exp Med source
- Not checked yetcites [17] Beerman, 2010, Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion, Proc Natl Acad Sci USA source
- Not checked yetcites [32] Cho, 2008, A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells, Blood source
- Not checked yetcites [33] Ho, 2017, Autophagy maintains the metabolism and function of young and old stem cells, Nature source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“aged HSC accumulate signatures of widespread DNA damage, including g-H2AX foci.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > DNA damage
What the sources say
- Not checked yetcites [49] Walter, 2015, Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells, Nature source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“in healthy elderly individuals, DNA mutations in specific loci are associated with the establishment of clonal hematopoiesis”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > DNA damage
What the sources say
- Not checked yetcites [52] Steensma, 2015, Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes, Blood source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 4
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The genetic or pharmacological depletion of senescent cells in mice has been shown to enhance regenerative potential and extend life span.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Senescence
What the sources say
- Partly supportedcites [57] Baker, 2016, Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan, Nature sourceExperimental — accuracy not yet measured
The Discussion reports that clearing p16Ink4a-positive cells with the INK-ATTAC system extended median lifespan in mice. The fat-progenitor results show preservation of adipogenesis-related measures, but not a general increase in regenerative potential; Extended Data Figure 10 reports that clearance during wound healing delayed wound closure. The study used a drug to activate a genetic clearance system, rather than demonstrating a separate pharmacological depletion method. (LLM, conf=0.88)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the pool of stem cells with reduced potential increases to compensate for loss of function of individual stem cells”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > HSC self-renewal and aging
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
In the paper
“the involvement of telomere shortening in the functional decline of HSC is particularly evident in human”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > DNA damage
What the sources say
- Not checked yetcites [53] Aubert, 2008, Telomeres and aging, Physiol Rev source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although some of these cell-intrinsic causes of aging are unlikely to be reversible, several others might allow interventions and thus could potentially be explored for pharmacological targeting”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Cell-intrinsic mechanisms that cause HSC aging
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“an age-dependent increase in the frequency of putative stem cells, coinciding with impaired functionality and reduced lymphoid potential, has also been in the human system.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > HSC self-renewal and aging
What the sources say
- Not checked yetcites [27] Kuranda, 2011, Age-related changes in human hematopoietic stem/progenitor cells, Aging Cell source
- Not checked yetcites [28] Pang, 2011, Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age, Proc Natl Acad Sci USA source
- Not checked yetcites [29] Rundberg Nilsson, 2016, Human and murine hematopoietic stem cell aging is associated with functional impairments and intrinsic megakaryocytic/erythroid bias, PLoS One source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“telomeres progressively shorten in human HSCs isolated from fetal liver, cord blood, or adult bone marrow, which is associated with a strongly reduced proliferative potential.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > HSC self-renewal and aging
What the sources say
- Not checked yetcites [26] Vaziri, 1994, Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age, Proc Natl Acad Sci USA source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“with each cell division, the potential of a HSC to contribute to blood cell production declines”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > HSC self-renewal and aging
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“during steady-state hematopoiesis the most primitive stem cells are largely inactive.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > HSC self-renewal and aging
What the sources say
- Not checked yetcites [18] Van Zant, 1984, Studies of hematopoietic stem cells spared by 5-fluorouracil, J Exp Med source
- Not checked yetcites [19] Bradford, 1997, Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment, Exp Hematol
- Not checked yetcites [20] Cheshier, 1999, In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells, Proc Natl Acad Sci USA source
- Not checked yetcites [21] Dykstra, 2007, Long-term propagation of distinct hematopoietic differentiation programs in vivo, Cell Stem Cell source
- Not checked yetcites [22] Morita, 2010, Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment, J Exp Med source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in effect they are likely to be highly interdependent and interconnected.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Cell-intrinsic mechanisms that cause HSC aging
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The most irreversible cause of HSC aging relates to the accumulation of random DNA damage.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > DNA damage
plaindirect- Asserted: fails — The authors may not put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“clonal hematopoiesis in otherwise healthy individuals increases the risk to develop leukemia, and, interestingly, cardiovascular disease, and thus is associated with increased mortality.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Clonal hematopoiesis in human
What the sources say
- Not checked yetcites [74] Zink, 2017, Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly, Blood source
- Not checked yetcites [75] Xie, 2014, Age-related mutations associated with clonal hematopoietic expansion and malignancies, Nat Med source
- Not checked yetcites [76] Jaiswal, 2014, Age-related clonal hematopoiesis associated with adverse outcomes, N Engl J Med source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“clonal hematopoiesis has been associated with increased incidence of atherosclerotic cardiovascular disease, suggesting that the function of monocytic cells derived from these aged stem cell clones is impaired.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Clonal hematopoiesis in human
What the sources say
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“high levels of reactive oxygen species, generated by mitochondria, accumulate in aged HSCs and compromise their functioning.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Impaired autophagy and mitochondrial activity
What the sources say
- Not checked yetcites [61] Ito, 2006, Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells, Nat Med source
- Not checked yetcites [62] Mohrin, 2015, Stem cell aging. A mitochondrial UPR-mediated metabolic checkpoint regulates hematopoietic stem cell aging, Science source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“aged red cells and aged platelets display impaired functioning”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Clonal hematopoiesis in human
What the sources say
- Not checked yetcites [82] Hoehn, 2015, Molecular mechanisms of erythrocyte aging, Biol Chem source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“impaired autophagy in aged HSCs appears to specifically result in the accumulation of mitochondria, which in turn induces metabolic stress.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Impaired autophagy and mitochondrial activity
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“pharmacological interventions in these signaling pathways are feasible and may be exploited to restore function in aged HSCs.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Impaired autophagy and mitochondrial activity
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“mutations in genes encoding for epigenetic enzymes have been found in either elderly people whose hematopoietic system has become oligoclonal, or in patients with myelodysplastic syndromes or acute myeloid leukemia.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Epigenetic reprogramming
What the sources say
- Not checked yetcites [52] Steensma, 2015, Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes, Blood source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mitochondrial dysfunctioning caused by accumulating mitochondrial DNA mutations has been shown to cause multiple hematopoietic defects that are typically seen in the elderly, but HSCs themselves appear to relatively resistant.”
§ HEMATOLOGIC DISEASE AT OLDER AGE Aging of hematopoietic stem cells > Impaired autophagy and mitochondrial activity
What the sources say
- Not checked yetcites [63] Norddahl, 2011, Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging, Cell Stem Cell source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
The formation of blood cells in mice and humans is conceptually identical.
“decades of research have shown that, conceptually, the formation of blood cells in mouse and human is identical”
The paper relies on this without support.
Many hematological conditions are strongly age-dependent.
“many hematological conditions are strongly age-dependent.”
The paper relies on this without support.
The purity of HSCs in transplantation experiments is never more than 50%.
“the purity of HSCs, at least when assayed in transplantation experiments, is never more than 50%.”
The paper relies on this without support.
Even after the most stringent enrichment protocols, many non-HSCs remain.
“even after the most stringent enrichment protocols, many non-HSCs (mostly progenitors) remain.”
The paper relies on this without support.
Genetic disparities are likely to be prominent in humans.
“These genetic disparities are also likely to be prominent in human.”
The paper relies on this without support.
During steady-state in vivo hematopoiesis, no conversion of hematopoietic progenitors into stem cells has been reported.
“but in the hematopoietic system such progenitor-to-stem cell conversions have never been described, at least not during steadystate in vivo hematopoiesis.”
The authors state this as an assumption.
Human HSC aging is not fundamentally different from mouse HSC aging.
“Assuming that in human HSC aging is not fundamentally different than in mice”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, aged HSCs have been shown to have lower regenerative potential and skewed differentiation toward the myeloid lineage instead of the lymphoid lineage [88].”
From Osteoimmunology of Fracture Healing. (2024) · cites this paper as [88]
Citations
Cites
1 retracted
Systemic signals regulate ageing and rejuvenation of blood stem cell niches
Mayack, S. R., Shadrach, J. L., Kim, F. S., & Wagers, A. J. (2010) · Nature · doi:10.1038/nature08749 · Cited by 137
RetractedLópez-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Cited by
Sorted by citations
Items 101–200 of 432
Cellular and Molecular Mechanisms Involved in Hematopoietic Stem Cell Aging as a Clinical Prospect
Montazersaheb, S., Ehsani, A., Fathi, E., & Farahzadi, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2713483 · Cited by 33
Why stem/progenitor cells lose their regenerative potential
Picerno, A., Stasi, A., Franzin, R., Curci, C., di Bari, I., Gesualdo, L., & Sallustio, F. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i11.1714 · Cited by 35
Hematopoiesis during Ontogenesis, Adult Life, and Aging
Belyavsky, A. V., Петинати, Н. А., & Дризе, Н. И. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179231 · Cited by 37
Fate of Hematopoiesis During Aging. What Do We Really Know, and What are its Implications?
Broxmeyer, H. E., Liu, Y., Kapur, R., Orschell, C. M., Aljoufi, A., Ropa, J. P., Trinh, T. L. P., Burns, S. S., & Capitano, M. L. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10065-y · Cited by 30
mTOR Signaling as a Regulator of Hematopoietic Stem Cell Fate
Fernandes, H., Moura, J., & Carvalho, E. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10131-z · Cited by 31
Aging and leukemic evolution of hematopoietic stem cells under various stress conditions
Kurosawa, S., & Iwama, A. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00138-3 · Cited by 29
The Emerging Link Between the Complement Cascade and Purinergic Signaling in Stress Hematopoiesis
Ratajczak, M. Z., Adamiak, M., Kucia, M., Tse, W. T., Ratajczak, J., & Wiktor-Jędrzejczak, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01295 · Cited by 29
Yu, Z., Zhu, Y., Chen, Y., Feng, C., Zhang, Z., Guo, X., Chen, H., Liu, X., Yu, Y., & Chen, H. (2024) · Nature Communications · doi:10.1038/s41467-024-53675-7 · Cited by 28
Osteoblast Lineage Support of Hematopoiesis in Health and Disease
Kim, M., Valderrábano, R. J., & Wu, J. Y. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4678 · Cited by 29
A novel Boolean network inference strategy to model early hematopoiesis aging
Hérault, L., Poplineau, M., Duprez, E., & Rémy, É. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.10.040 · Cited by 30
Rosales-Alvarez, R. E., Rettkowski, J., Herman, J. S., Dumbović, G., Cabezas‐Wallscheid, N., & Grün, D. (2023) · Genome biology · doi:10.1186/s13059-023-02974-1 · Cited by 31
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Hieber, C., Grabbe, S., & Bros, M. (2023) · Biomolecules · doi:10.3390/biom13071085 · Cited by 30
Biological implications of clonal hematopoiesis
Luis, T. C., Wilkinson, A. C., Beerman, I., Jaiswal, S., & Shlush, L. I. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.08.004 · Cited by 29
Solomon, M. P., DeLay, M. L., & Reynaud, D. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24041 · Cited by 26
DRAG in situ barcoding reveals an increased number of HSPCs contributing to myelopoiesis with age
Urbanus, J. H. M., Cosgrove, J., Beltman, J. B., Elhanati, Y., Moral, R. D. A., Conrad, C., van Heijst, J. W. J., Tubeuf, E., Velds, A., Kok, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37167-8 · Cited by 25
Developmental programming of adult haematopoiesis system
Balistreri, C. R., Garagnani, P., Madonna, R., Vaiserman, A. M., & Melino, G. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100918 · Cited by 29
Clonal Hematopoiesis and Acute Ischemic Stroke Outcomes
Lee, E., An, H. Y., Lim, J., Park, K., Choi, S., Jeong, H., Kang, D., Yang, W., Kim, J., Ko, S., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26754 · Cited by 25
Allegra, A., Caserta, S., Mirabile, G., & Gangemi, S. (2023) · Cells · doi:10.3390/cells12192392 · Cited by 30
Totani, H., Matsumura, T., Yokomori, R., Umemoto, T., Takihara, Y., Yang, C., Chua, L. H., Watanabe, A., Sanda, T., & Suda, T. (2025) · Nature Aging · doi:10.1038/s43587-025-00828-y · Cited by 28
van den Berk, P. C. M., Lancini, C., Serresi, M., Sánchez-Bailón, M. P., Hulsman, D., Pritchard, C., Song, J., Schmitt, M. J., Tanger, E., Popp, O., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108533 · Cited by 25
Rejuvenation of Tissue Stem Cells by Intrinsic and Extrinsic Factors
Cai, Y., Wang, S., Qu, J. T., Belmonte, J. C. I., & Liu, G. (2021) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szab012 · Cited by 28
The tumor suppression theory of aging
Wolf, A. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111583 · Cited by 27
PLZF limits enhancer activity during hematopoietic progenitor aging
Poplineau, M., Vernerey, J., Platet, N., N’Guyen, L., Hérault, L., Esposito, M., Saurin, A. J., Guilouf, C., Iwama, A., & Duprez, E. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz174 · Cited by 25
The circuitry between ribosome biogenesis and translation in stem cell function and ageing
Sharifi, S., da Costa, H. F. R., & Bierhoff, H. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111282 · Cited by 22
Lin, R. J., Elias, H. K., & van den Brink, M. R. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674093 · Cited by 22
The multifaceted role of mitochondria in HSC fate decisions: energy and beyond
Filippi, M. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.10.001 · Cited by 24
Goldman, E. A., Spellman, P. T., & Agarwal, A. (2023) · Molecular Case Studies · doi:10.1101/mcs.a006251 · Cited by 25
Sensitivity to targeted UBA1 inhibition in a myeloid cell line model of VEXAS syndrome
Chiaramida, A., Obwar, S. G., Nordstrom, A. E. H., Ericsson, M., Saldanha, A. L., Ivanova, E. V., Griffin, G. K., Khan, D. H., & Belizaire, R. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010531 · Cited by 22
The mitochondrial metabolic checkpoint in stem cell aging and rejuvenation
Mu, W., Ohkubo, R., Widjaja, A., & Chen, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111254 · Cited by 24
Megakaryocytes as the Regulator of the Hematopoietic Vascular Niche
Zhan, H., & Kaushansky, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.912060 · Cited by 23
New insight into the causes, consequences, and correction of hematopoietic stem cell aging
Mansell, E., Lin, D. S. Y., Loughran, S. J., Milsom, M. D., & Trowbridge, J. J. (2023) · Experimental Hematology · doi:10.1016/j.exphem.2023.07.002 · Cited by 21
Wu, L., Lin, Q., Chatla, S., Amarachintha, S. P., Wilson, A. F., Atale, N., Gao, Z. J., Joseph, J., Wolff, E. V., & Du, W. (2023) · Blood · doi:10.1182/blood.2022018212 · Cited by 20
Tan, Y., Wu, Q., & Zhou, F. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102993 · Cited by 20
Clonal hematopoiesis and bone marrow failure syndromes
Paşca, S., & Gondek, L. P. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101273 · Cited by 21
Symmetric and asymmetric activation of hematopoietic stem cells
Loeffler, D., & Schroeder, T. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000644 · Cited by 24
To portray clonal evolution in blood cancer, count your stem cells
Lyne, A.-M., Laplane, L., & Perié, L. (2020) · Blood · doi:10.1182/blood.2020008407 · Cited by 26
Chen, Z., Mao, Z., Tang, W., Shi, Y., Liu, J., & You, Y. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00517-1 · Cited by 27
Choi, D. H., Lee, K. E., Oh, S.-Y., Lee, S., Jo, B. S., Lee, J., Park, J., Park, Y. J., Park, K. D., Jo, I., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121156 · Cited by 19
Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma Survival
Molinaro, A. M., Wiencke, J. K., Warrier, G., Koestler, D. C., Chunduru, P., Lee, J. Y., Hansen, H. M., Lee, S., Anguiano, J., Rice, T., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab195 · Cited by 19
Linking cell cycle to hematopoietic stem cell fate decisions
Treichel, S., & Filippi, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1231735 · Cited by 20
The regulatory role of CD36 in hematopoiesis beyond fatty acid uptake
Ashaq, M. S., Zhang, S., Xu, M., Li, Y., & Zhao, B. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122442 · Cited by 19
Zhang, J., Han, X., Zhao, Y., Xue, X., & Fan, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.021 · Cited by 19
Kim, J. H., Hwang, S., Son, H., Kim, D., Kim, I. B., Kim, M.-H., Sim, N. S., Kim, D. S., Ha, Y.-J. J., Lee, J., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010404 · Cited by 18
Udroiu, I., & Sgura, A. (2019) · Biogerontology · doi:10.1007/s10522-019-09804-7 · Cited by 18
Stem cell aging: The upcoming era of proteins and metabolites
Schüler, S. C., Gebert, N., & Ori, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111288 · Cited by 18
Choi, D. H., Oh, S.-Y., Choi, J. K., Lee, K. E., Lee, J., Park, Y. J., Jo, I., & Park, Y. S. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01860-y · Cited by 18
Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments
Zhang, Z., Liu, P., Song, Y., Ma, L., Xu, Y., Lei, J., Tong, B., Zhu, D., Liang, H., Wang, H., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70417 · Cited by 20
Prada, D., Belsky, D. W., & Baccarelli, A. (2021) · La Medicina del Lavoro · doi:10.23749/mdl.v112i1.10826 · Cited by 17
Ginsenoside Rg1 as a Potential Regulator of Hematopoietic Stem/Progenitor Cells
He, F., & Yao, G. (2021) · Stem Cells International · doi:10.1155/2021/4633270 · Cited by 17
Recent advances in understanding telomere diseases
Carvalho, V. S., Gomes, W. R., & Calado, R. T. (2022) · Faculty Reviews · doi:10.12703/r/11-31 · Cited by 20
Regulation of Hematopoietic Stem Cell Fate and Malignancy
Cho, H. J., Lee, J., Yoon, S. R., Lee, H. G., & Jung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134780 · Cited by 18
Hematopoietic stem cell regeneration through paracrine regulation of the Wnt5a/Prox1 signaling axis
Lin, Q., Wu, L., Chatla, S., Chowdhury, F. A., Atale, N., Joseph, J., & Du, W. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155914 · Cited by 16
Harada, K., Yahata, T., Onizuka, M., Ishii, T., Ibrahim, A. A., Kikkawa, E. F., Gondo, Y., & Ando, K. (2022) · Stem Cells · doi:10.1093/stmcls/sxac072 · Cited by 16
Regulatory cellular and molecular networks in the bone microenvironment during aging
Zhang, L., Wang, Z., Zhang, Y., Ji, R., Li, Z., Zou, J., & Gao, B. (2024) · Life Medicine · doi:10.1093/lifemedi/lnae019 · Cited by 19
Gaulin, C., Kelemen, K., & Yi, C. A. (2022) · Life · doi:10.3390/life12081135 · Cited by 16
Franzin, R., Stasi, A., Castellano, G., & Gesualdo, L. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1507-2_6 · Cited by 14
Stem cell decoupling underlies impaired lymphoid development during aging
Jang, G., Contreras, S., Esteva, E., Upadhaya, S., Feng, J., Adams, N. M., Richard, É., Awatramani, R. B., Sawai, C. M., & Reizis, B. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302019120 · Cited by 19
Rejuvenating aged stem cells: therapeutic strategies to extend health and lifespan
Matteini, F., Montserrat‐Vazquez, S., & Florian, M. C. (2024) · FEBS Letters · doi:10.1002/1873-3468.14865 · Cited by 16
Gao, D., Yi, W., Liu, B., Zhang, C.-E., Yang, C.-C., Zeng, L., Li, L., Luo, G., Zhang, L., Ju, Z., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.027 · Cited by 15
Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential
Zhang, C., Hao, T., Bortoluzzi, A., Chen, M.-H., Wu, X., Wang, J., Ermel, R. W., Kim, Y., Chen, S., & Chen, W. (2024) · Oncogene · doi:10.1038/s41388-024-03197-9 · Cited by 17
Pre-surgery immune profiles of adult glioma patients
Bracci, P. M., Rice, T., Hansen, H. M., Francis, S. S., Lee, S., Mccoy, L. S., Shrestha, P., Warrier, G., Clarke, J. L., Molinaro, A. M., et al. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-04047-y · Cited by 15
MicroRNAs in hematopoietic stem cell aging
Luinenburg, D., & de Haan, G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111281 · Cited by 13
Selenoprotein-mediated redox regulation shapes the cell fate of HSCs and mature lineages
Aoyama, Y., Yamazaki, H., Nishimua, K., Nomura, M., Shigehiro, T., Suzuki, T., Zang, W., Tatara, Y., Ito, H., Hayashi, Y., et al. (2025) · Blood · doi:10.1182/blood.2024025402 · Cited by 14
Wang, J., Zhang, L., Cui, X., Xu, X., Guo, R., Li, K., Zhang, L., Xu, B., Jiang, C., & Yu, Y. (2025) · Science Immunology · doi:10.1126/sciimmunol.adr2041 · Cited by 15
Leukemic Stem Cell: A Mini-Review on Clinical Perspectives
Barreto, I. V., Pessoa, F. M. C. D. P., Machado, C. B., Pantoja, L. D. C., Ribeiro, R. M., Lopes, G. S., de Moraes, M. E. A., de Moraes, M. O., de Souza, L. E. B., Burbano, R. M. R., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.931050 · Cited by 14
Implications of stress-induced gene expression for hematopoietic stem cell aging studies
Konturek-Cieśla, A., Olofzon, R., Kharazi, S., & Bryder, D. (2024) · Nature Aging · doi:10.1038/s43587-023-00558-z · Cited by 13
Nitta, E., Itokawa, N., Yabata, S., Koide, S., Hou, L.-B., Oshima, M., Aoyama, K., Saraya, A., & Iwama, A. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.153 · Cited by 14
Lee, S., Wong, H., Castiglione, M. A., Murphy, M. M., Kaushansky, K., & Zhan, H. (2022) · Stem Cells · doi:10.1093/stmcls/sxac005 · Cited by 12
Xiong, Y., Chen, T., Chen, L., & Cai, R. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s399568 · Cited by 15
Immune senescence: A key player in cancer biology
Yang, Y., Fan, L., Li, M., & Wang, Z. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.001 · Cited by 15
Zhou, H., Nguyen, L., Arnesano, C., Ando, Y., Raval, M. H., Rodgers, J. T., Fraser, S. E., Lu, R., & Shen, K. (2020) · iScience · doi:10.1016/j.isci.2020.100831 · Cited by 13
Genetics of autosomal mosaic chromosomal alteration (mCA)
Liu, X., Kamatani, Y., & Terao, C. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00964-4 · Cited by 13
On the correlation between telomere shortening rate and life span
Udroiu, I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920300117 · Cited by 13
Hematopoietic Stem Cells and RegenerationPreprint
Biermann, M., & Reya, T. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040774 · Cited by 14
Zhang, Q., Liu, Y., Tang, R., Kong, S., Lv, D., Li, H., Yang, H., & Lin, L. (2024) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2024.100567 · Cited by 12
Greco, S. J., Ayer, S., Guiro, K., Sinha, G., DONNELLY, R. J., El-Far, M. H., Pamarthi, S. H., Sandiford, O. A., Gergues, M., Sherman, L. S., et al. (2021) · Aging · doi:10.18632/aging.203689 · Cited by 12
Shang, D., Li, Z., Tan, X., Liu, H., & Tu, Z. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12863 · Cited by 12
Wais, V., Bunjes, D. W., Kuchenbauer, F. C., & Sorror, M. L. (2018) · Expert Review of Hematology · doi:10.1080/17474086.2018.1509703 · Cited by 13
Aging-induced MCPH1 translocation activates necroptosis and impairs hematopoietic stem cell function
He, H., Wang, Y., Tang, B., Dong, Q., Wu, C., Sun, W., & Wang, J. (2024) · Nature Aging · doi:10.1038/s43587-024-00609-z · Cited by 11
Xinyi, Y., Vladimirovich, R. I., Beeraka, N. M., Satyavathi, A., Kamble, D., Nikolenko, V. N., Lakshmi, A. N., Basappa, B., Padmanabha Reddy, Y., Fan, R., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04008-4 · Cited by 11
Jiang, P., Cai, Y., Zhou, X., Yang, J., Tong, Y., Huang, C., Qiu, H., Zhou, K., Xu, X., Zhang, Y., et al. (2022) · Clinical Transplantation · doi:10.1111/ctr.14844 · Cited by 11
Lysosomes and Their Role in Regulating the Metabolism of Hematopoietic Stem Cells
Arif, T. (2022) · Biology · doi:10.3390/biology11101410 · Cited by 11
Andrzejczak, K., Sternak, A., Witkowski, W., & Ponikowska, M. (2025) · Cells · doi:10.3390/cells14181442 · Cited by 10
Aging of the Hematopoietic System: Mechanisms, Consequences, and Systemic Interactions
Miyawaki, M., Hashimoto, S., Ogawa, S., & Kase, Y. (2026) · Aging Cell · doi:10.1111/acel.70385 · Cited by 10
Wang, Z., Du, J., Vergel-Rodriguez, M., Nogalska, A., & Lu, R. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00922-w · Cited by 10
Hemangiosarcoma Cells Promote Conserved Host-derived Hematopoietic Expansion
Kim, J. H., Schulte, A. J., Sarver, A. L., Lee, D., Angelos, M. G., Frantz, A. M., Forster, C. L., O’Brien, T. D., Cornax, I., O'Sullivan, M. G., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0441 · Cited by 10
Koide, S., Oshima, M., Kamiya, T., Zheng, Z., Liu, Z., Rizq, O., Nishiyama, A., Murakami, K., Yamada, Y., Nakajima-Takagi, Y., et al. (2025) · Blood · doi:10.1182/blood.2024025776 · Cited by 10
Persistent DNA damage–induced NLRP12 improves hematopoietic stem cell function
Lin, Q., Wu, L., Ma, Z., Chowdhury, F. A., Mazumder, H. H., & Du, W. (2020) · JCI Insight · doi:10.1172/jci.insight.133365 · Cited by 10
Butler, M., Ambrosi, T. H., Murphy, M. P., & Chan, C. K. F. (2022) · Advances in Geriatric Medicine and Research · doi:10.20900/agmr20220006 · Cited by 12
Divide and Rule: Mitochondrial Fission Regulates Quiescence in Hematopoietic Stem Cells
Luis, T. C., Lawson, H., & Kranc, K. R. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.02.009 · Cited by 10
Molecular and functional characteristics of megakaryocytes and platelets in aging
Esparza, O., Higa, K. C., & Davizon‐Castillo, P. (2020) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000601 · Cited by 11
Clonal haematopoiesis of emerging significance
Hammond, D. E., & Loghavi, S. (2021) · Pathology · doi:10.1016/j.pathol.2021.02.005 · Cited by 10
Opportunities and Challenges in Stem Cell Aging
Larijani, B. A., Heravani, N. F., Alaei, S., Rezaei–Tavirani, M., Alavi-Moghadam, S., Payab, M., Goodarzi, P., Tayanloo-Beik, A., Aghayan, H. R., & Arjmand, B. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_624 · Cited by 10
p38α plays differential roles in hematopoietic stem cell activity dependent on aging contexts
Sorimachi, Y., Karigane, D., Ootomo, Y., Kobayashi, H., Morikawa, T., Otsu, K., Kubota, Y., Okamoto, S., Goda, N., & Takubo, K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100563 · Cited by 11
Growing and aging of hematopoietic stem cells
Udroiu, I., & Sgura, A. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i6.594 · Cited by 10
Cell Therapy in Heart Failure with Preserved Ejection Fraction
Frljak, S., Poglajen, G., & Vrtovec, B. (2022) · Cardiac failure review · doi:10.15420/cfr.2021.21 · Cited by 10
Ratliff, M., Garton, J. W., James, J. A., & Webb, C. F. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00198-6 · Cited by 11
Watanuki, S., Kobayashi, H., Sugiura, Y., Yamamoto, M., Karigane, D., Shiroshita, K., Sorimachi, Y., Fujita, S., Morikawa, T., Koide, S., et al. (2023) · eLife · doi:10.7554/elife.87674 · Cited by 19
Biomarkers for aging of blood – how transferable are they between mice and humans?
Tharmapalan, V., & Wagner, W. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104600 · Cited by 9
Chae, D., Park, H. S., Kim, K.-M., Yu, A., Park, J. H., Oh, M., Choi, S. W., Ryu, J., Dunbar, C. E., Yoo, H. M., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01416-1 · Cited by 10
Metadata
- Authors
- de Haan, G., & Lazare, S. S.
- Affiliations
- European Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
- University Medical Center Groningen (NL)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2018-02-01
- Volume
- 131
- Issue
- 5
- Pages
- 479-487
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2768409010
- Semantic Scholar
- 767a7a803b0d377cfb03d909da859be3e4df29bc
- Cited by
- 432
- References
- 107
- Citations by year
- 2026: 41 · 2025: 46 · 2024: 68 · 2023: 62 · 2022: 55 · 2021: 67 · 2020: 51 · 2019: 27 · 2018: 15
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- European Commission (316964)
- ZonMw
- KWF Kankerbestrijding (2014-7178, RUG 2014-7178)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- hematopoietic stem cells, stem cell aging, cellular senescence, self-renewal, regenerative capacity, molecular mechanisms of aging
- MeSH terms
- Aging, Animals, Autophagy, Hematopoiesis, Hematopoietic Stem Cells, Humans, Mitochondria, Cellular Senescence, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
